Crossref
Generic clopidogrel–the medicines agency’s perspective
Generics and Biosimilars Initiative Journal · 2012
DOI: 10.5639/gabij.2012.0102.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Generics and Biosimilars Initiative Journal, 2012. Verfasst von Christoph Baumgärtel.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Baumgärtel, C. (2012). Generic clopidogrel–the medicines agency’s perspective. Generics and Biosimilars Initiative Journal. https://doi.org/10.5639/gabij.2012.0102.019
Vancouver
Baumgärtel C. Generic clopidogrel–the medicines agency’s perspective. Generics and Biosimilars Initiative Journal. 2012. doi:10.5639/gabij.2012.0102.019
BibTeX
@article{Baumgrtel2012,
author = {Baumgärtel, Christoph},
title = {Generic clopidogrel–the medicines agency’s perspective},
journal = {Generics and Biosimilars Initiative Journal},
year = {2012},
doi = {10.5639/gabij.2012.0102.019}
}
EUVIMED